Related Experiment Video
Updated: Apr 3, 2026

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
p53 mediated apoptosis in osteosarcoma MG-63 cells by inhibition of FANCD2 gene expression
Peng Xia1, Yifu Sun2, Changjun Zheng1
1Department of Orthopedics, The Second Hospital of Jilin University Changchun 130000, China.
Purpose:
The aim of this study was to investigate the association between osteosarcoma (OS) and Fanconi anemia (FA) related pathways and the molecular mechanisms.
Methods:
siRNA for Fanconi anemia complementation group D2 (FANCD2) was constructed and transfected into the osteosarcoma cell line MG-63 cells. Expression of TP53INP1, p53, p21, caspase-9, and caspase-3 mRNA in MG-63 cells were examined by real-time fluorescence quantitative PCR, and the protein levels were also determined by western blot.
Results:
After silence of the FANCD2 gene in MG-63 cells, cell proliferation was inhibited, cell cycle was arrested and cell apoptosis was induced. The apoptosis was mediated by the p53 signaling pathway. After FANCD2 expression was inhibited, TP53INP1 gene expression was up-regulated, phosphorylation of p53 was promoted and the p21 protein was activated, leading to cell cycle arrested in G1, finally resulted in caspase-dependent cell apoptosis.
Conclusions:
Inhibition of FANCD2 gene expression can induce apoptosis of osteosarcoma cells, which indicated that FANCD2 played an important role in the development of osteosarcoma and it might be a potential target for treatment of osteosarcoma.
Insights
Inhibiting Fanconi anemia complementation group D2 (FANCD2) in osteosarcoma cells stops proliferation and triggers apoptosis via the p53 pathway. FANCD2 is a potential therapeutic target for osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma (OS) is a primary bone malignancy.
- Fanconi anemia (FA) is a rare genetic disorder associated with increased cancer risk.
- The molecular mechanisms linking FA pathways to OS development require further elucidation.
Purpose of the Study:
- To investigate the association between osteosarcoma and Fanconi anemia (FA) related pathways.
- To explore the molecular mechanisms underlying this association.
Main Methods:
- siRNA targeting Fanconi anemia complementation group D2 (FANCD2) was used to inhibit its expression in the MG-63 osteosarcoma cell line.
- Gene expression (TP53INP1, p53, p21, caspase-9, caspase-3) was analyzed using real-time quantitative PCR.
- Protein levels were assessed via Western blot.
Main Results:
- FANCD2 gene inhibition in MG-63 cells led to suppressed proliferation, cell cycle arrest, and induced apoptosis.
- Apoptosis was mediated through the p53 signaling pathway.
- Inhibition of FANCD2 upregulated TP53INP1, promoted p53 phosphorylation, and activated p21, causing G1 cell cycle arrest and caspase-dependent apoptosis.
Conclusions:
- FANCD2 plays a significant role in osteosarcoma development.
- Inhibiting FANCD2 induces osteosarcoma cell apoptosis.
- FANCD2 represents a potential therapeutic target for osteosarcoma treatment.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway

